The Friday Effect: Firm Lobbying, the Timing of Drug Safety Alerts, and Drug Side Effects

References

• Accountemps (2013) Workplace productivity peaks on Tuesday. News release (December 16), Accountemps, Menlo Park, CA. Accessed May 27, 2019, https://www.prnewswire.com/news-releases/workplace-productivity-peaks-on-tuesday-236004751.html.Google Scholar
• Advera Health Analytics (2013) Post FDA-approval drug safety data: Why they are vital and how they can be made accessible, actionable, and predictable. White paper, Advera Health Analytics, Santa Rosa, CA.Google Scholar
• Ahmed P, Gardella J, Nanda S (2002) Wealth effect of drug withdrawals on firms and their competitors. Financial Management 31(3):21–41.Crossref, Google Scholar
• Alkhateeb FM, Khanfar NM, Clauson KA (2009) Characteristics of physicians who frequently see pharmaceutical sales representatives. J. Hospital Marketing Public Relations 19(1):2–14.Crossref, Google Scholar
• Beckers D, van Hooff M, van der Linden D, Kompier M, Taris T, Geurts S (2008) A diary study to open up the black box of overtime work among university faculty members. Scandinavian J. Work Environ. Health 34(3):213–223.Crossref, Google Scholar
• Carpenter D, Chattopadhyay J, Moffitt S, Nall C (2012) The complications of controlling agency time discretion: FDA review deadlines and postmarket drug safety. Amer. J. Political Sci. 56(1):98–114.Crossref, Google Scholar
• Center for Drug Evaluation and Research (2007) Drug safety information—FDA’s communication to the public. Report, U.S. Department of Health and Human Services, Washington, DC.Google Scholar
• Cheah E, Chan W, Chieng C (2007) The corporate social responsibility of pharmaceutical product recalls: An empirical examination of US and UK markets. J. Bus. Ethics 76(4):427–449.Crossref, Google Scholar
• Chen Y, Ganesan S, Liu Y (2009) Does a firm’s product-recall strategy affect its financial value? An examination of strategic alternatives during product-harm crises. J. Marketing 73(6):214–226.Crossref, Google Scholar
• Deephouse D, Heugens P (2009) Linking social issues to organizational impact: The role of infomediaries and the infomediary process. J. Bus. Ethics 86(4):541–553.Crossref, Google Scholar
• DellaVigna S, Pollet J (2009) Investor inattention and Friday earnings announcements. J. Finance 64(2):709–749.Crossref, Google Scholar
• Dowdell T, Govindaraj S, Jain P (1992) The Tylenol incident, ensuing regulation, and stock prices. J. Financial Quant. Anal. 27(2):283–301.Crossref, Google Scholar
• Dusetzina S, Higashi A, Dorsey E, Conti R, Huskamp H, Zhu S, Garfield C, Alexander G (2012) Impact of FDA drug risk communications on healthcare utilization and health behaviors: a systematic review. Med. Care 50(6):466–478.Crossref, Google Scholar
• Edersheim J, Stern T (2009) Liability associated with prescribing medications. Primary Care Companion J. Clinical Psychiatry 11(3):115–119.Crossref, Google Scholar
• Hainmueller J (2012) Entropy balancing for causal effects: A multivariate reweighting method to produce balanced samples in observational studies. Political Anal. 20(1):25–46.Crossref, Google Scholar
• Harrison D, Hulin C (1989) Investigations of absenteeism: Using event history models to study the absence-taking process. J. Appl. Psych. 74(2):300–316.Crossref, Google Scholar
• Heinrich J (2000) Adverse drug events: Substantial problem but magnitude uncertain. Testimony Before the Committee on Health, Education, Labor, and Pensions, U.S. Senate. GAO Report T-HEHS-00-53, U.S. General Accounting Office, Washington, DC.Google Scholar
• Herrmann M, Rockoff J (2012) Worker absence and productivity: Evidence from teaching. J. Labor Econom. 30(4):749–782.Crossref, Google Scholar
• Hirshleifer D, Lim SS, Teoh SH (2009) Driven to distraction: Extraneous events and underreaction to earnings news. J. Finance 64(5):2289–2325.Crossref, Google Scholar
• Hoffman AJ, Ocasio W (2001) Not all events are attended equally: Toward a middle-range theory of industry attention to external events. Organ. Sci. 12(4):414–434.Link, Google Scholar
• Hoffman K, Demakas A, Dimbil M, Tatonetti N, Erdman C (2014) Stimulated reporting: The impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS). Drug Safety 37(11):971–980.Crossref, Google Scholar
• Hurren K, Taylor T, Jaber L (2011) Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert. Diabetes Res. Clinical Practice 93(1):49–55.Crossref, Google Scholar
• Issac T, Weissman JS, Davis RB (2009) Overrides of medication alerts in ambulatory care. Arch. Internal Med. 169(3):305–311.Crossref, Google Scholar
• Johns G, Al Hajj R (2016) Frequency vs. time lost measures of absenteeism: Is the voluntariness distinction an urban legend? J. Organ. Behav. 37(3):456–479.Crossref, Google Scholar
• King G, Tomz M, Wittenberg J (2000) Making the most of statistical analyses: Improving interpretation and presentation. Amer. J. Political Sci. 44(2):347–361.Crossref, Google Scholar
• Lazarou J, Pomeranz B, Corey P (1998) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279(15):1200–1205.Crossref, Google Scholar
• Light D, Lexchin J, Darrow J (2013) Institutional corruption of pharmaceuticals and the myth of safe and effective drugs. J. Law Medicine Ethics 41(3):590–600.Crossref, Google Scholar
• Louis H, Sun A (2010) Investor inattention and the market reaction to merger announcements. Management Sci. 56(10):1781–1793.Link, Google Scholar
• Madsen PM, Rodgers ZJ (2015) Looking good by doing good: The antecedents and consequences of stakeholder attention to corporate disaster relief. Strategic Management J. 36(5):776–794.Crossref, Google Scholar
• Michaely R, Rubin A, Vedrashko A (2016) Further evidence on the strategic timing of earnings news: Joint analysis of weekdays and times of day. J. Accounting Econom. 62(1):24–45.Crossref, Google Scholar
• Miller R, Murnane R, Willett J (2008) Do worker absences affect productivity? The case of teachers. Internat. Labour Rev. 147(1):71–89.Crossref, Google Scholar
• Mintzes B, Lexchin J, Sutherland JM, Beaulieu MD, Wilkes MS, Durrieu G, Reynolds E (2013) Pharmaceutical sales representatives and patient safety: A comparative prospective study of information quality in Canada, France and the United States. J. General Internal Medicine 28(10):1368–1375.Crossref, Google Scholar
• Nader I, Pietschnig J, Voracek M (2012) Academic workload, research productivity, and end of life: A single-case historiometric study. Psych. Rep. 110(3):701–708.Crossref, Google Scholar
• Ocasio W (1997) Toward an attention-based view of the firm. Strategic Management J. 18(1):187–206.Crossref, Google Scholar
• Ocasio W (2011) Attention to attention. Organ. Sci. 22(5):1286–1296.Link, Google Scholar
• Ojeleye O, Avery A, Gupta V, Boyd M (2013) The evidence for the effectiveness of safety alerts in electronic patient medication record systems at the point of pharmacy order entry: A systematic review. BMC Medical Informatics Decision Making 13(1):69–79.Crossref, Google Scholar
• Peters PG (2009) Twenty years of evidence on the outcomes of malpractice claims. Clinical Orthopaedics Related Res. 467(2):352–357.Crossref, Google Scholar
• Porterfield A, Engelbert K, Coustasse A (2014) Electronic prescribing: Improving the efficiency and accuracy of prescribing in the ambulatory care setting. Perspect. Health Inform. Management 11(Spring):1.Google Scholar
• Sakaeda T, Tamon A, Kadoyama K, Okuno Y (2013) Data mining of the public version of the FDA adverse event reporting system. Internat. J. Medical Sci. 10(7):796–803.Crossref, Google Scholar
• Sotak K, Spain S, Dionne S, Yammarino F (2015) A within-person approach to observing cyclical patterns of motivation. Acad. Management Proc. 2015(1):12933.Crossref, Google Scholar
• Van de Sijs H, Aarts J, Vulto A, Berg M (2006) Overriding of drug safety alerts in computerized physician order entry. J. Amer. Med. Inform. Assoc. 13(2):138–147.Crossref, Google Scholar
• Wittayanukorn S, Qian J, Johnson B, Hansen R (2017) Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS). J. Oncol. Pharm. Practice 23(2):93–102.Crossref, Google Scholar
• Zelner B (2009) Using simulation to interpret results from logit, probit, and other nonlinear models. Strategic Management J. 30(12):1335–1348.Crossref, Google Scholar